Sharp John P 4
4 · PhaseBio Pharmaceuticals Inc · Filed Nov 23, 2021
Insider Transaction Report
Form 4
Sharp John P
CFO and Secretary
Transactions
- Award
Common Stock
2021-11-19$2.01/sh+2,017$4,054→ 59,741 total
Footnotes (1)
- [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).